A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects
Clinical trial NCT06014853 · COMPLETED
Trial details
- NCT number
- NCT06014853
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2023-10-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.